Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapy.

Ansari C, Tikhomirov GA, Hong SH, Falconer RA, Loadman PM, Gill JH, Castaneda R, Hazard FK, Tong L, Lenkov OD, Felsher DW, Rao J, Daldrup-Link HE.

Small. 2014 Feb 12;10(3):566-75, 417. doi: 10.1002/smll.201301456. Epub 2013 Aug 27.

2.

Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles.

Daldrup-Link HE.

Mol Imaging. 2017 Jan-Dec;16:1536012117730950. doi: 10.1177/1536012117730950.

PMID:
28929923
3.

PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.

Liu Y, Yang K, Cheng L, Zhu J, Ma X, Xu H, Li Y, Guo L, Gu H, Liu Z.

Nanomedicine. 2013 Oct;9(7):1077-88. doi: 10.1016/j.nano.2013.02.010. Epub 2013 Mar 8.

PMID:
23499668
4.

Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.

Zhu L, Zhou Z, Mao H, Yang L.

Nanomedicine (Lond). 2017 Jan;12(1):73-87. Epub 2016 Nov 23. Review.

PMID:
27876448
5.

A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival.

Mohanty S, Chen Z, Li K, Morais GR, Klockow J, Yerneni K, Pisani L, Chin FT, Mitra S, Cheshier S, Chang E, Gambhir SS, Rao J, Loadman PM, Falconer RA, Daldrup-Link HE.

Mol Cancer Ther. 2017 Sep;16(9):1909-1921. doi: 10.1158/1535-7163.MCT-17-0022. Epub 2017 Jun 28.

PMID:
28659432
6.

Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.

Li L, Tong R, Li M, Kohane DS.

Acta Biomater. 2016 Mar;33:34-9. doi: 10.1016/j.actbio.2016.01.039. Epub 2016 Jan 27.

7.

Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.

Tassa C, Shaw SY, Weissleder R.

Acc Chem Res. 2011 Oct 18;44(10):842-52. doi: 10.1021/ar200084x. Epub 2011 Jun 10. Review.

8.

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Atkinson JM, Falconer RA, Edwards DR, Pennington CJ, Siller CS, Shnyder SD, Bibby MC, Patterson LH, Loadman PM, Gill JH.

Cancer Res. 2010 Sep 1;70(17):6902-12. doi: 10.1158/0008-5472.CAN-10-1440. Epub 2010 Jul 27.

9.

Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.

Lee GY, Qian WP, Wang L, Wang YA, Staley CA, Satpathy M, Nie S, Mao H, Yang L.

ACS Nano. 2013 Mar 26;7(3):2078-89. doi: 10.1021/nn3043463. Epub 2013 Mar 12.

10.

Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.

Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R.

J Control Release. 2011 Feb 10;149(3):314-22. doi: 10.1016/j.jconrel.2010.10.030. Epub 2010 Nov 1.

11.

Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.

Jiao Y, Sun Y, Tang X, Ren Q, Yang W.

Small. 2015 Apr 24;11(16):1962-74. doi: 10.1002/smll.201402297. Epub 2014 Dec 12.

PMID:
25504837
12.

Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Yang L, Peng XH, Wang YA, Wang X, Cao Z, Ni C, Karna P, Zhang X, Wood WC, Gao X, Nie S, Mao H.

Clin Cancer Res. 2009 Jul 15;15(14):4722-32. doi: 10.1158/1078-0432.CCR-08-3289. Epub 2009 Jul 7.

13.

Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.

Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, Danhier F, Préat V.

J Control Release. 2014 Nov 28;194:82-91. doi: 10.1016/j.jconrel.2014.07.059. Epub 2014 Aug 29.

PMID:
25178270
14.

Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy.

Zhang M, Cao Y, Wang L, Ma Y, Tu X, Zhang Z.

ACS Appl Mater Interfaces. 2015 Mar 4;7(8):4650-8. doi: 10.1021/am5080453. Epub 2015 Feb 20.

PMID:
25672225
15.

Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.

Liu Y, Feng L, Liu T, Zhang L, Yao Y, Yu D, Wang L, Zhang N.

Nanoscale. 2014 Mar 21;6(6):3231-42. doi: 10.1039/c3nr05647c. Epub 2014 Feb 6.

PMID:
24500240
16.

Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.

Bakhtiary Z, Saei AA, Hajipour MJ, Raoufi M, Vermesh O, Mahmoudi M.

Nanomedicine. 2016 Feb;12(2):287-307. doi: 10.1016/j.nano.2015.10.019. Epub 2015 Dec 18. Review.

PMID:
26707817
17.

In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles.

Hsieh WJ, Liang CJ, Chieh JJ, Wang SH, Lai IR, Chen JH, Chang FH, Tseng WK, Yang SY, Wu CC, Chen YL.

Int J Nanomedicine. 2012;7:2833-42. doi: 10.2147/IJN.S32154. Epub 2012 Jun 7.

18.

Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.

Zarrin A, Sadighian S, Rostamizadeh K, Firuzi O, Hamidi M, Mohammadi-Samani S, Miri R.

Int J Pharm. 2016 Mar 16;500(1-2):62-76. doi: 10.1016/j.ijpharm.2015.12.051. Epub 2015 Dec 22.

PMID:
26721723
19.

Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy.

Xie J, Liu G, Eden HS, Ai H, Chen X.

Acc Chem Res. 2011 Oct 18;44(10):883-92. doi: 10.1021/ar200044b. Epub 2011 May 6.

20.

Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use.

Gutova M, Frank JA, D'Apuzzo M, Khankaldyyan V, Gilchrist MM, Annala AJ, Metz MZ, Abramyants Y, Herrmann KA, Ghoda LY, Najbauer J, Brown CE, Blanchard MS, Lesniak MS, Kim SU, Barish ME, Aboody KS, Moats RA.

Stem Cells Transl Med. 2013 Oct;2(10):766-75. doi: 10.5966/sctm.2013-0049. Epub 2013 Sep 6.

Supplemental Content

Support Center